Drug · DIN 02087324
BROMOCRIPTINE
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since January 13, 2013; first marketed December 31, 1994.
- Drug Identification Number (DIN)
- 02087324
- Company (DIN owner)
- AA Pharma Inc.Toronto, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Bromocriptine N04BC01
- Class
- Human
- Record last updated
- June 18, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| BROMOCRIPTINE (BROMOCRIPTINE MESYLATE) | 2.5 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- September 7, 2012: NOC 13643New Drug Submission (NDS) · Manufacturer and product name change
- May 24, 1994: NOC 5524New Drug Submission (NDS)
Other DINs named BROMOCRIPTINE
- DIN 02230454 · Marketed
- DIN 02238192 · Cancelled Post Market
- DIN 02238193 · Cancelled Post Market